Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 3,970 filings

Top spenders & firms Spend by issue

Clear
Q1
INTEGRUS STRATEGIES, LLC for AXADVOCACY GOVERNMENT RELATIONS ON BEHALF OF STRATA CRITICAL
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $10,000.00 income
Aviation/Airlines/Airports, Health Issues, Transportation
View →
Q1
MAYER BROWN LLP for OURARING INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $10,000.00 income
Health Issues, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q1
AMERICAN COLLEGE OF CARDIOLOGY for AMERICAN COLLEGE OF CARDIOLOGY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Tobacco
View →
Q1
MISSION ROLL CALL for MISSION ROLL CALL
1st Quarter (Jan 1 - Mar 31) 2026 · South Carolina · House · Senate
Veterans, Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q1
ALSTON & BIRD LLP for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income
Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for PHRMA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income
Budget/Appropriations, Medicare/Medicaid, Health Issues
View →
Q1
BALLARD SPAHR LLP for GRAIL, INC. (FORMERLY GRAIL, LLC)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
HOOPER, LUNDY & BOOKMAN, P.C. for DIALYSIS CLINIC, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
NOVO NORDISK INC. for NOVO NORDISK INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark
View →
Q1
THE METROHEALTH SYSTEM for THE METROHEALTH SYSTEM
1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Pharmacy
View →
Q1
TODD STRATEGY GROUP for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View →
Q1
PORTERFIELD, FETTIG & SEARS, LLC for VANTIVE US HEALTHCARE LLC
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income
Health Issues, Foreign Relations
View →
Q1
TODD STRATEGY GROUP for BIOGEN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for SAREPTA THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $90,000.00 income
Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
1T
PORTERFIELD, FETTIG & SEARS, LLC for TAKEDA PHARMACEUTICALS AMERICA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income
Health Issues
View →
Q1
POLICY INTEGRATION PARTNERS, LLC for SIXTEENTHIRTY FUND
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income
Health Issues
View →
Q1
TARPLIN, DOWNS & YOUNG, LLC for CRINETICS PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
PORTERFIELD, FETTIG & SEARS, LLC for NATIONAL BRAIN TUMOR SOCIETY
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $20,000.00 income
Health Issues
View →
Q1
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Defense, Health Issues, Immigration
View →
Q1
TODD STRATEGY GROUP for BIODESIX, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate · $30,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
ALSTON & BIRD LLP for CLARITEV
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
TODD STRATEGY GROUP for BAYER CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues
View →
Q1
UNIVERSITY OF CONNECTICUT for UNIVERSITY OF CONNECTICUT
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · House · Senate
Science/Technology, Energy/Nuclear, Agriculture, Education
View →
Q1
TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View →
Previous Page 48 of 159 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem